AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...

India's Zydus Lifesciences reported third-quarter profit above analysts' expectations on Wednesday, driven by strong demand for its generic drugs in its key U.S. market.

The Ahmedabad-based pharmaceutical company’s revenue from operations grew 17 per cent to ₹5,269.1 crore compared to the same period last year. The shares of Zydus Lifesciences Limited were ...

Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

(Image Credits: Pixabay) Zydus Lifesciences Ltd on Wednesday reported a profit of Rs 1023.80 crore during the third quarter of FY25, posting a growth of 29.66 per cent in comparison to Rs 789.60 ...

Pharmaceutical manufacturing encompasses all processes involved in the manufacturing and production of biological and medical products, botanical drugs, and herbs, as well as other pharmaceutical ...

Who are peers of Zydus Lifesciences Ltd? The peers of Zydus Lifesciences Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Mankind Pharma Ltd, Torrent Pharmaceuticals ...

Recursion Pharmaceuticals has a flashy drug development platform. It has a lot to prove about whether that platform's use of AI is helpful. Some power players have backed it with significant ...